Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 2 (2024): December

Uncovering the Knowledge Landscape of Food-Drug Interactions Among Medical Professionals



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.9390
Published
August 3, 2024

Abstract

Background: Drug-food interactions (DFIs) can alter drug pharmacokinetics and pharmacodynamics, impacting patient outcomes. Health care professionals (HCPs) play a critical role in managing these interactions. Specific Background: Despite their significance, the awareness of DFIs among Iraqi medical professionals is inadequately documented. Knowledge Gap: There is a lack of comprehensive studies evaluating the knowledge of DFIs among medical professionals in Iraq, which is crucial for improving patient care and therapeutic efficacy. Aims: This study aimed to evaluate the knowledge of food-drug interactions among Iraqi medical professionals, including medical students, newly graduated doctors, and junior doctors. Methods: A cross-sectional study was conducted using a self-administered questionnaire with 20 questions evaluating knowledge on common DFIs. Results: The study revealed a concerning lack of knowledge about DFIs among participants, with junior doctors scoring an average of 7.1 out of 15, newly graduated doctors 6.38, and sixth-grade medical students 5.27. Only 13% felt knowledgeable about DFIs, while 31.7% acknowledged their insufficient understanding. Notably, knowledge on interactions such as tyramine-rich foods with antidepressants and grapefruit juice with statins was limited. Novelty: This study provides the first comprehensive assessment of DFI knowledge among Iraqi medical professionals, highlighting significant gaps and educational needs. Implications: The findings underscore the necessity for enhanced educational programs targeting DFIs in medical curricula, ensuring HCPs are equipped to counsel patients effectively, thereby improving patient safety and therapeutic outcomes. These results emphasize the importance of targeted educational interventions to bridge the knowledge gap, ultimately contributing to better health outcomes and informed patient care in Iraq.

Highlights:

  • Knowledge Gaps: Iraqi medical professionals lack understanding of common food-drug interactions.

  • Education Needed: Enhanced training on interactions is essential in medical curricula.

  • Patient Safety: Improving knowledge will lead to better patient outcomes.

Keywords: Food–Drug Interactions, Knowledge, Drug Interaction, Medical Students

References

  1. S. Polaka, K. Rajpoot, M. Tekade, M. C. Sharma, and R. K. Tekade, “Food–Drug Interactions and Their Implications on Oral Drug Bioavailability,” in Pharmacokinetics and Toxicokinetic Considerations, Academic Press, Jan. 2022, pp. 263-289.
  2. G. M. Veerman, K. G. Hussaarts, F. G. Jansman, S. W. Koolen, R. W. van Leeuwen, and R. H. Mathijssen, “Clinical Implications of Food–Drug Interactions with Small-Molecule Kinase Inhibitors,” The Lancet Oncology, vol. 21, no. 5, pp. e265-e279, May 2020.
  3. H. Nomani, A. T. Moghadam, S. A. Emami, A. H. Mohammadpour, T. P. Johnston, and A. Sahebkar, “Drug Interactions of Cola-Containing Drinks,” Clinical Nutrition, vol. 38, no. 6, pp. 2545-2551, Dec. 2019.
  4. Z. Vinarov et al., “Impact of Gastrointestinal Tract Variability on Oral Drug Absorption and Pharmacokinetics: An UNGAP Review,” European Journal of Pharmaceutical Sciences, vol. 162, p. 105812, Jul. 2021.
  5. R. E. Tao, S. Prajapati, J. N. Pixley, A. Grada, and S. R. Feldman, “Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy,” Antibiotics, vol. 12, no. 7, p. 1152, Jul. 2023.
  6. D. G. Bailey, “Better to Avoid Grapefruit with Certain Statins,” The American Journal of Medicine, vol. 129, no. 11, p. e301, Nov. 2016.
  7. S. K. Eagles, A. S. Gross, and A. J. McLachlan, “The Effects of Cruciferous Vegetable-Enriched Diets on Drug Metabolism: A Systematic Review and Meta-Analysis of Dietary Intervention Trials in Humans,” Clinical Pharmacology & Therapeutics, vol. 108, no. 2, pp. 212-227, Aug. 2020.
  8. N. Edinoff et al., “Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors,” Health Psychology Research, vol. 10, no. 4, 2022.
  9. S. Tan and S. W. Lee, “Warfarin and Food, Herbal or Dietary Supplement Interactions: A Systematic Review,” British Journal of Clinical Pharmacology, vol. 87, no. 2, pp. 352-374, Feb. 2021.
  10. S. Varanasi-Diaz, “10 Commonly Prescribed Medications and the Foods That Should Be Avoided with Them,” Nutrition, Feb. 2024.
  11. E. A. McAninch, “How Should I Take My Levothyroxine?” Clinical Thyroidology, vol. 34, no. 11, pp. 483-486, Nov. 2022.
  12. S. A. Alhubail, M. M. Alharthi, F. F. Alsayyah, and N. S. Younis, “Healthcare Professionals and Undergraduate Students’ Knowledge Toward Drug-Food Interactions in the Eastern Region of Saudi Arabia,” Journal of Multidisciplinary Healthcare, Dec. 2023, pp. 2883-2892.
  13. N. Degefu, M. Getachew, and F. Amare, “Knowledge of Drug–Food Interactions Among Healthcare Professionals Working in Public Hospitals in Ethiopia,” Journal of Multidisciplinary Healthcare, Jan. 2022, pp. 2635-2645.
  14. J. M. Benni, M. K. Jayanthi, R. Basavaraj, and M. J. Renuka, “Knowledge and Awareness of Food and Drug Interactions (FDI): A Survey Among Health Care Professionals,” International Journal of Pharmacology and Clinical Sciences, vol. 1, no. 4, 2012.
  15. A. Radwan, A. Sweileh, W. A. Shraim, A. Hroub, J. Elaraj, and N. Shraim, “Evaluation of Community Pharmacists’ Knowledge and Awareness of Food–Drug Interactions in Palestine,” International Journal of Clinical Pharmacy, vol. 40, pp. 668-675, Jun. 2018.
  16. M. D. Dantas et al., “Interactions of Tetracyclines with Milk Allergenic Protein (Casein): A Molecular and Biological Approach,” Journal of Biomolecular Structure and Dynamics, vol. 38, no. 18, pp. 5389-5400, Dec. 2020.
  17. C. S. Tan and S. W. Lee, “Warfarin and Food, Herbal or Dietary Supplement Interactions: A Systematic Review,” British Journal of Clinical Pharmacology, vol. 87, no. 2, pp. 352-374, Feb. 2021.
  18. P. M. Leite, M. A. Martins, and R. O. Castilho, “Review on Mechanisms and Interactions in Concomitant Use of Herbs and Warfarin Therapy,” Biomedicine & Pharmacotherapy, vol. 83, pp. 14-21, Oct. 2016.
  19. S. Ala et al., “Dose Administration Time from Before Breakfast to Before Dinner Affect Thyroid Hormone Levels?” Caspian Journal of Internal Medicine, vol. 6, no. 3, p. 134, 2015.
  20. P. O. Samuel et al., “Lifestyle Modifications for Preventing and Managing Cardiovascular Diseases,” Sport Sciences for Health, vol. 20, no. 1, pp. 23-36, Mar. 2024.
  21. E. Wenzler, K. Sprandel-Harris, and K. A. Rodvold, “Drug-Food Interactions,” in Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions, 2018, pp. 87-162.
  22. M. Ates and S. Sahin, “Interaction of Statins with Grapefruit Juice,” Fabad Journal of Pharmaceutical Sciences, vol. 48, no. 2, pp. 337-358, Aug. 2023.
  23. M. A. Baraka et al., “Awareness of Statin–Food Interactions Using Grapefruit as an Example: A Cross-Sectional Study in Eastern Province of Saudi Arabia,” Journal of Pharmaceutical Health Services Research, vol. 12, no. 4, pp. 545-551, Nov. 2021.
  24. H. A. Elshenawi and Y. F. Elazeem, “Nurses' Awareness and Perception of Drug-Drug and Drug-Food Interactions,” Evidence-Based Nursing Research, vol. 2, no. 2, 2020.
  25. B. F. Johnson, S. M. Rodin, K. Hoch, and V. Shekar, “The Effect of Dietary Fiber on the Bioavailability of Digoxin in Capsules,” Journal of Clinical Pharmacology, vol. 27, pp. 487–490, 1987.
  26. T. Pollard and M. J. Morra, “Fate of Tetracycline Antibiotics in Dairy Manure-Amended Soils,” Environmental Reviews, vol. 26, no. 1, pp. 102-112, 2018.
  27. W. S. Adio, A. C. Ogunwole, and F. I. Mary, “A Review on Drug-Diet Interaction,” World News of Natural Sciences, vol. 43, pp. 108-125, 2022.
  28. G. E. Lim, T. Li, and H. S. Buttar, “Interactions of Grapefruit Juice and Cardiovascular Medications: A Potential Risk of Toxicity,” Experimental & Clinical Cardiology, vol. 8, no. 2, p. 99, 2003.
  29. T. Wu et al., “Mechanistic Insight into Interactions Between Tetracycline and Two Iron Oxide Minerals with Different Crystal Structures,” Chemical Engineering Journal, vol. 366, pp. 577-586, Jun. 2019.
  30. M. Zawiah et al., “Food-Drug Interactions: Knowledge Among Pharmacists in Jordan,” PLOS ONE, vol. 15, no. 6, p. e0234779, Jun. 2020.

Downloads

Download data is not yet available.